UnitedHealth Stock News

UnitedHealth Group (UNH) shares have been on the decline since the CEO of its UnitedHealthcare unit was killed in New York City on Dec. 4.

Investors seemed to shrug off the meltdown on Thursday. Some Dow Jones laggards of this period tried to rebound as well.

UnitedHealth Group shares have dropped over 20% due to public backlash and political rhetoric; current valuation suggests 17-30% upside potential. IAC remains undervalued in a SOTP framework, with MGM Resorts presenting significant upside due to its clean balance sheet and undervalued core US gaming business. MGM's US gaming business is undervalued at ~9x free cash flow; fair value suggests 25-...

The stock price of the health insurer has tumbled 21% since a top executive was murdered on Dec. 4.

The U.S.' bluechip stock index is mired in its longest stretch in the red since 1978, a potentially concerning signal for investors enjoying an otherwise sanguine period for stocks, though Tuesday's losses are largely tied to a singular company—UnitedHealth Group—and gains remain healthy over a longer timeframe.

The U.S.' bluechip stock index is on the cusp of suffering its longest stretch in the red since 1978, a potentially concerning signal for investors enjoying an otherwise sanguine period for stocks, though Tuesday's losses are largely tied to a singular company—UnitedHealth Group—and gains remain healthy over a longer timeframe.

Shares in major healthcare companies fell yesterday after president-elect Donald Trump made comments that he wanted to “knock out” prescription drug industry middlemen. The fall makes this yet another week since the killing of UnitedHealth CEO Brian Thompson that the business practices of companies that operate America's private healthcare system have come under increased scrutiny.

Shares of health insurers operating pharmacy benefit managers fell on Monday after U.S. President-elect Donald Trump called them middlemen who drive up costs and said he plans to eliminate their role.